Sean P. Harbison

Sean Harbison practices at Penn Presbyterian Medical Center in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Sean Harbison's NPI, 1841288875, was assigned on October 13, 2005. Sean Harbison graduated from Temple University School of Medicine in 1986. Sean Harbison holds Pennsylvania license MD039974E.

Sean Harbison's primary practice is Penn Presbyterian Medical Center, at 51 North 39th Street, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-8000.

Sean Harbison's primary practice is Penn Presbyterian Medical Center in Philadelphia, Pennsylvania, part of University of Pennsylvania. Sean Harbison is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Sean Harbison to 3 more hospitals and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Sean Harbison practices, 6 sites in all. Vendor and product names are available with a free account.

Surgery is Sean Harbison's primary specialty in the NPI Registry, under taxonomy code 208600000X. Sean Harbison is licensed in Pennsylvania.

CMS data shows 242 Medicare services from Sean Harbison across 7 procedure codes in 2024, for 216 Medicare patients. Medicare paid $24,796 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 216 Medicare patients who saw Sean Harbison in 2024. The largest group is 65 to 74, with 108 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Sean Harbison's median patient age at 59, with 51% women.

In 2024, Sean Harbison wrote 73 Medicare Part D claims for 70 patients. 100% of them were for generic drugs. CMS names the drug for 62 of them, across 2 drugs with 11 or more claims each, at $201 in total drug cost. In 2023, CMS named 76 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Sean Harbison for performance year 2024, reported as part of a group. Sean Harbison accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Sean Harbison as offering telehealth. CMS counts 25 procedures of hernia repair - groin (open) by Sean Harbison, more than 97% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Sean Harbison, published from 2010 to 2024. The most frequent topics are Electric Stimulation Therapy, Gastroparesis and Hernia, Ventral. Sean Harbison's most frequent co-authors are John Patrick Fischer, MD, Henry P. Parkman, MD and Daniel Boucek.

CMS Open Payments shows 41 general payments to Sean Harbison from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 46% of the total. Daiichi Sankyo Inc. paid the most, $9,789.

Sean Harbison graduated from Temple University School of Medicine in 1986.